Anxiety and Risk Perception in Parents of Children Identified by Population Screening as High Risk for Type 1 Diabetes

© 2023 by the American Diabetes Association..

OBJECTIVE: To assess anxiety and risk perception among parents whose children screened positive for islet autoantibodies, indicating elevated risk for type 1 diabetes (T1D).

RESEARCH DESIGN AND METHODS: The Autoimmunity Screening for Kids (ASK) study identified 319 children age 1 to 17 years at risk for T1D via screening for islet autoantibodies; 280 children with confirmed islet autoantibodies and their caregivers enrolled in a follow-up education and monitoring program to prevent diabetic ketoacidosis at diagnosis. Parents completed questionnaires at each monitoring visit, including a 6-item version of the State Anxiety Inventory (SAI), to assess anxiety about their child developing T1D, and a single question to assess risk perception.

RESULTS: At the first ASK follow-up monitoring visit, mean parental anxiety was elevated above the clinical cutoff of 40 (SAI 46.1 ± 11.2). At the second follow-up monitoring visit (i.e., visit 2), mean anxiety remained elevated but started to trend down. Approximately half (48.9%) of parents reported their child was at increased risk for T1D at the initial follow-up monitoring visit (visit 1). Parents of children with more than one islet autoantibody and a first-degree relative with T1D were more likely to report their child was at increased risk.

CONCLUSIONS: Most parents of autoantibody-positive children have high anxiety about their child developing T1D. Information about the risk of developing T1D is difficult to convey, as evidenced by the wide range of risk perception reported in this sample.

Errataetall:

CommentIn: Diabetes Care. 2023 Dec 1;46(12):2123-2125. - PMID 38011529

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:46

Enthalten in:

Diabetes care - 46(2023), 12 vom: 01. Dez., Seite 2155-2161

Sprache:

Englisch

Beteiligte Personen:

O'Donnell, Holly K [VerfasserIn]
Rasmussen, Cristy Geno [VerfasserIn]
Dong, Fran [VerfasserIn]
Simmons, Kimber M [VerfasserIn]
Steck, Andrea K [VerfasserIn]
Frohnert, Brigitte I [VerfasserIn]
Bautista, Kimberly [VerfasserIn]
Rewers, Marian J [VerfasserIn]
Baxter, Judith [VerfasserIn]
ASK Study Group [VerfasserIn]
Rewers, Marian J [Sonstige Person]
Bautista, Kimberly [Sonstige Person]
Baxter, Judith [Sonstige Person]
Felipe-Morales, Daniel [Sonstige Person]
Dong, Fran [Sonstige Person]
Driscoll, Kimberly [Sonstige Person]
Frohnert, Brigitte I [Sonstige Person]
Rasmussen, Cristy Geno [Sonstige Person]
Gesualdo, Patricia [Sonstige Person]
Hoffman, Michelle [Sonstige Person]
Karban, Rachel [Sonstige Person]
O'Donnell, Holly K [Sonstige Person]
Pauley, Meghan [Sonstige Person]
Sepulveda, Flor [Sonstige Person]
Silva, Crystal [Sonstige Person]
Simmons, Kimber M [Sonstige Person]
Steck, Andrea K [Sonstige Person]
Taki, Iman [Sonstige Person]
Waugh, Kathleen [Sonstige Person]
Jia, Xiaofan [Sonstige Person]
Yu, Liping [Sonstige Person]
Liu, Edwin [Sonstige Person]
Stahl, Marisa [Sonstige Person]
McQueen, R Brett [Sonstige Person]
Norris, Jill M [Sonstige Person]
Frost, Holly [Sonstige Person]
O'Leary, Sonja [Sonstige Person]
Middlemist, Martha [Sonstige Person]

Links:

Volltext

Themen:

Autoantibodies
Journal Article

Anmerkungen:

Date Completed 29.11.2023

Date Revised 29.11.2023

published: Print

CommentIn: Diabetes Care. 2023 Dec 1;46(12):2123-2125. - PMID 38011529

Citation Status MEDLINE

doi:

10.2337/dc23-0350

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM361707460